Annual EBITDA
-$26.06 M
+$11.82 M+31.20%
December 31, 2023
Summary
- As of February 12, 2025, MREO annual EBITDA is -$26.06 million, with the most recent change of +$11.82 million (+31.20%) on December 31, 2023.
- During the last 3 years, MREO annual EBITDA has risen by +$189.91 million (+87.94%).
- MREO annual EBITDA is now -202.23% below its all-time high of $25.49 million, reached on December 31, 2021.
Performance
MREO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$14.37 M
-$2.70 M-23.13%
September 30, 2024
Summary
- As of February 12, 2025, MREO quarterly EBITDA is -$14.37 million, with the most recent change of -$2.70 million (-23.13%) on September 30, 2024.
- Over the past year, MREO quarterly EBITDA has dropped by -$2.70 million (-23.13%).
- MREO quarterly EBITDA is now -3085.37% below its all-time high of -$451.00 thousand, reached on June 30, 2023.
Performance
MREO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$43.41 M
-$8.82 M-25.49%
September 30, 2024
Summary
- As of February 12, 2025, MREO TTM EBITDA is -$43.41 million, with the most recent change of -$8.82 million (-25.49%) on September 30, 2024.
- Over the past year, MREO TTM EBITDA has dropped by -$8.82 million (-25.49%).
- MREO TTM EBITDA is now -292.85% below its all-time high of -$11.05 million, reached on March 21, 2023.
Performance
MREO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MREO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.2% | -23.1% | -25.5% |
| 3 y3 years | +87.9% | - | - |
| 5 y5 years | +40.0% | - | - |
MREO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -202.2% | +31.2% | -3085.4% | at low | -292.9% | at low |
| 5 y | 5-year | -202.2% | +87.9% | -3085.4% | at low | -292.9% | at low |
| alltime | all time | -202.2% | +87.9% | -3085.4% | at low | -292.9% | at low |
Mereo BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.37 M(+23.1%) | -$43.41 M(+25.5%) |
| Jun 2024 | - | -$11.67 M(+39.5%) | -$34.59 M(+48.0%) |
| Mar 2024 | - | -$8.37 M(-7.1%) | -$23.37 M(-10.3%) |
| Dec 2023 | -$26.06 M(-31.2%) | -$9.01 M(+62.3%) | -$26.06 M(+52.8%) |
| Sep 2023 | - | -$5.55 M(+1130.4%) | -$17.05 M(+48.3%) |
| Jun 2023 | - | -$451.00 K(-95.9%) | -$11.50 M(+4.1%) |
| Mar 2023 | - | -$11.05 M | -$11.05 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$37.87 M(-248.6%) | - | - |
| Dec 2021 | $25.49 M(-111.8%) | - | - |
| Dec 2020 | -$215.96 M(+374.3%) | - | - |
| Dec 2019 | -$45.53 M(+4.9%) | - | - |
| Dec 2018 | -$43.41 M(-30.8%) | - | - |
| Dec 2017 | -$62.73 M(+51.7%) | - | - |
| Dec 2016 | -$41.34 M | - | - |
FAQ
- What is Mereo BioPharma annual EBITDA?
- What is the all time high annual EBITDA for Mereo BioPharma?
- What is Mereo BioPharma annual EBITDA year-on-year change?
- What is Mereo BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Mereo BioPharma?
- What is Mereo BioPharma quarterly EBITDA year-on-year change?
- What is Mereo BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for Mereo BioPharma?
- What is Mereo BioPharma TTM EBITDA year-on-year change?
What is Mereo BioPharma annual EBITDA?
The current annual EBITDA of MREO is -$26.06 M
What is the all time high annual EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high annual EBITDA is $25.49 M
What is Mereo BioPharma annual EBITDA year-on-year change?
Over the past year, MREO annual EBITDA has changed by +$11.82 M (+31.20%)
What is Mereo BioPharma quarterly EBITDA?
The current quarterly EBITDA of MREO is -$14.37 M
What is the all time high quarterly EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high quarterly EBITDA is -$451.00 K
What is Mereo BioPharma quarterly EBITDA year-on-year change?
Over the past year, MREO quarterly EBITDA has changed by -$2.70 M (-23.13%)
What is Mereo BioPharma TTM EBITDA?
The current TTM EBITDA of MREO is -$43.41 M
What is the all time high TTM EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high TTM EBITDA is -$11.05 M
What is Mereo BioPharma TTM EBITDA year-on-year change?
Over the past year, MREO TTM EBITDA has changed by -$8.82 M (-25.49%)